EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against United Therapeutics
Corporation - UTHR
Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of
shareholders of United Therapeutics Corporation (NASDAQ: UTHR) resulting from allegations that United Therapeutics may have issued
materially misleading business information to the investing public.
On July 27, 2017, United Therapeutics disclosed that it recorded a $210 million accrual relating to a potential settlement in
connection with a U.S. Department of Justice investigation of United Therapeutics concerning possible violations of the Federal
Anti-Kickback Statute and the Federal False Claims Act. On this news, shares of United Therapeutics fell sharply during intraday
trading on July 27, 2017, damaging investors.
Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by United Therapeutics investors. If you purchased
shares of United Therapeutics on or before July 27, 2017, please visit the firm’s website at http://www.rosenlegal.com/cases-1170.html for more information. You may also contact Phillip Kim or Kevin Chan
of Rosen Law Firm toll free at 866-767-3653 or via email at pkim@rosenlegal.com or kchan@rosenlegal.com.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder
derivative litigation.
Attorney Advertising. Prior results do not guarantee a similar outcome.
The Rosen Law Firm, P.A.
Laurence Rosen, Esq.
Phillip Kim, Esq.
Kevin Chan, Esq.
275 Madison Avenue, 34th Floor
New York, NY 10016
Tel: 212-686-1060
Toll Free: 866-767-3653
Fax: 212-202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
kchan@rosenlegal.com
www.rosenlegal.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20170727006530/en/